Literature DB >> 3160688

Inhibitory effect of high-level transcription of the bacteriophage lambda nutL region on transcription of rRNA in Escherichia coli.

R A Sharrock, R L Gourse, M Nomura.   

Abstract

Transcription of the bacteriophage lambda nutL region from the PL promoter on a multicopy plasmid in Escherichia coli causes a reduction in growth rate and in transcription of rRNA relative both to total transcription and to transcription of tRNAs that are not encoded in rRNA operons. These observations support the hypothesis, previously based on nut site DNA sequence homology, that the phage lambda and rRNA antitermination systems are related.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160688      PMCID: PMC219178          DOI: 10.1128/jb.163.2.704-708.1985

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  27 in total

1.  Specificity of the bacteriophage lambda N gene product (pN): nut sequences are necessary and sufficient for antitermination by pN.

Authors:  B de Crombrugghe; M Mudryj; R DiLauro; M Gottesman
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

Review 2.  Regulation of bacterial growth, RNA, and protein synthesis.

Authors:  D P Nierlich
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

3.  Coliphage lambdanutL-: a unique class of mutants defective in the site of gene N product utilization for antitermination of leftward transcription.

Authors:  J S Salstrom; W Szybalski
Journal:  J Mol Biol       Date:  1978-09-05       Impact factor: 5.469

4.  Expression of spacer tRNA genes in ribosomal RNA transcription units carried by hybrid Col E1 plasmids in E. coli.

Authors:  T Ikemura; M Nomura
Journal:  Cell       Date:  1977-08       Impact factor: 41.582

5.  Genetic characterization of a bacterial locus involved in the activity of the N function of phage lambda.

Authors:  D I Friedman; L S Baron
Journal:  Virology       Date:  1974-03       Impact factor: 3.616

6.  Insertions of Tn 10 into an E. coli ribosomal RNA operon are incompletely polar.

Authors:  E A Morgan
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

7.  A class of rifR RNA polymerase mutations that interferes with the expression of coliphage lambda late gene.

Authors:  N Sternberg
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

8.  Cooperative effects of bacterial mutations affecting lambda N gene expression. I. Isolation and characterization of a nusB mutant.

Authors:  D I Friedman; M Baumann; L S Baron
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

9.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

10.  Pausing and attenuation of in vitro transcription in the rrnB operon of E. coli.

Authors:  R E Kingston; M J Chamberlin
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

View more
  6 in total

Review 1.  Antitermination mechanisms in rRNA operons of Escherichia coli.

Authors:  E A Morgan
Journal:  J Bacteriol       Date:  1986-10       Impact factor: 3.490

2.  Specific binding of Escherichia coli ribosomal protein S1 to boxA transcriptional antiterminator RNA.

Authors:  J Mogridge; J Greenblatt
Journal:  J Bacteriol       Date:  1998-04       Impact factor: 3.490

3.  Processing of Escherichia coli 16S rRNA with bacteriophage lambda leader sequences.

Authors:  M Krych; R Sirdeshmukh; R Gourse; D Schlessinger
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

4.  Lethal effect of lambda DNA terminase in recombination deficient Escherichia coli.

Authors:  H Murialdo
Journal:  Mol Gen Genet       Date:  1988-07

Review 5.  Control of rRNA transcription in Escherichia coli.

Authors:  C Condon; C Squires; C L Squires
Journal:  Microbiol Rev       Date:  1995-12

6.  SuhB Associates with Nus Factors To Facilitate 30S Ribosome Biogenesis in Escherichia coli.

Authors:  Navjot Singh; Mikhail Bubunenko; Carol Smith; David M Abbott; Anne M Stringer; Ronald Shi; Donald L Court; Joseph T Wade
Journal:  MBio       Date:  2016-03-15       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.